Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Plus Therapeutics, Inc. (PSTV) had Free Cash Flow per Share of $-1.06 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$1.03M |
|
$-6.95M |
|
-- |
|
$1.03M |
|
$8.15M |
|
$-7.12M |
|
$0.17M |
|
$-6.95M |
|
$-6.95M |
|
$-6.95M |
|
$-6.95M |
|
$-6.95M |
|
$-6.95M |
|
$-7.12M |
|
$-7.02M |
|
6.65M |
|
6.65M |
|
$-1.05 |
|
$-1.05 |
|
| Balance Sheet Financials | |
$18.03M |
|
$1.01M |
|
$1.89M |
|
$19.92M |
|
$7.96M |
|
-- |
|
-- |
|
$7.96M |
|
$11.96M |
|
$11.29M |
|
$11.96M |
|
6.86M |
|
| Cash Flow Statement Financials | |
$-6.24M |
|
$-8.53M |
|
$9.04M |
|
$8.76M |
|
$3.02M |
|
$-5.74M |
|
$1.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.27 |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
100.00% |
|
-692.51% |
|
-692.51% |
|
-- |
|
-675.68% |
|
-675.68% |
|
$-7.06M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
0.76 |
|
118.19 |
|
-58.07% |
|
-61.52% |
|
-34.88% |
|
-58.07% |
|
$1.74 |
|
|
Free Cash Flow per Share |
$-1.06 |
$-0.94 |
|